Study guide
20.3 Acute Severe Epistaxis & Airway Obstruction
ABFM Family Medicine Certification Study Guide Exam
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Exam Structure, Blueprint & Clinical Decision-Making
1.1 Exam Blueprint, FMCLA vs. One-Day Exam & Board Scoring 1.2 Clinical Reasoning, Test-Taking Strategy & Ambiguity Management 1.3 Evidence-Based Medicine & Clinical Practice Guidelines in Primary Care
2 Chapter 2: Healthcare Systems, Practice Management & Quality
2.1 Practice Management, Billing, Coding & Documentation 2.2 Quality Improvement, Patient Safety & Diagnostic Stewardship 2.3 Interprofessional Team-Based Care & Care Coordination
3 Chapter 3: Ethics, Law, Biostatistics & Health Equity
3.1 Medical Ethics, Informed Consent & Surrogate Decision-Making 3.2 Biostatistics, Clinical Epidemiology & Diagnostic Test Interpretation 3.3 Social Determinants of Health, Health Equity & Cultural Humility 3.4 Physician Wellness, Burnout Prevention & Professionalism
4 Chapter 4: Lifestyle Counseling & Behavior Change
4.1 Alcohol Use Screening & Brief Intervention 4.2 Illicit Drug & Cannabis Counseling 4.3 Tobacco & Vaping Cessation Counseling
5 Chapter 5: Nutrition, Physical Activity & Chronic Disease Prevention
5.1 Dietary Counseling for Obesity & Chronic Disease Prevention 5.2 Exercise Prescription & Physical Activity Counseling 5.3 Genetic Risk Assessment & Family History Counseling
6 Chapter 6: Routine Adult Immunizations
6.1 ACIP Adult Respiratory Vaccines: Influenza, COVID-19, RSV & Pneumococcal 6.2 ACIP Adult Non-Respiratory Vaccines: Tdap, Shingrix, HPV & Hep B 6.3 Immunizations in Special Populations: Pregnancy, Asplenia & Immunocompromise
7 Chapter 7: Pediatric Health Maintenance & Surveillance
7.1 Newborn Examination & Early Postnatal Care 7.2 Well-Child Care, Developmental Surveillance & Milestones 7.3 Pediatric & Adolescent Screening: Vision, Hearing, Anemia & Lead 7.4 Pediatric Oral Health, Dental Screening & Fluoride
8 Chapter 8: Behavioral Health & Safety Screening
8.1 Primary Care Depression, Anxiety & Behavioral Health Screening 8.2 Domestic Violence, Intimate Partner Violence & Firearm Safety 8.3 Occupational Health & Recreational Safety Counseling
9 Chapter 9: Adult Preventive Screening: Cardiovascular & Metabolic
9.1 Cardiovascular Disease & Hypertension Screening 9.2 Type 2 Diabetes Screening & Prediabetes Risk Stratification 9.3 Abdominal Aortic Aneurysm & Osteoporosis Screening
10 Chapter 10: Adult Cancer Screening: Breast & Gynecologic
10.1 Breast Cancer Screening & Risk-Assessment 10.2 Cervical Cancer Screening & ASCCP Algorithms 10.3 Skin Cancer Clinical Assessment & Counseling
11 Chapter 11: Adult Cancer Screening: Colorectal, Lung & Prostate
11.1 Colorectal Cancer Screening Modalities & Intervals 11.2 Lung Cancer Screening with Low-Dose CT 11.3 Prostate Cancer Screening & Shared Decision-Making
12 Chapter 12: Sexual Health, Infectious Disease Screening & Contraception
12.1 Sexual Health Counseling & Risk-Reduction Strategies 12.2 STI Screening: Chlamydia, Gonorrhea, Syphilis & Trichomoniasis 12.3 Bloodborne Infectious Disease Screening: HIV & Hepatitis C
13 Chapter 13: Reproductive Life Planning, Lactation & Preoperative Care
13.1 Preconception Planning & Comprehensive Contraception Management 13.2 Lactation Support & Breastfeeding Counseling 13.3 Preoperative Medical Evaluation & Pre-Participation Sports Exam
14 Chapter 14: Emergent Cardiovascular Conditions
14.1 Acute Coronary Syndromes & Myocardial Infarction 14.2 Acute Chest Pain Risk Stratification & Triage 14.3 Acute or Critical Valvular Heart Emergencies
15 Chapter 15: Cardiac Arrhythmias, Heart Failure & Hypertensive Crises
15.1 Acute Atrial & Ventricular Arrhythmias 15.2 Acute Decompensated Heart Failure & Cardiogenic Shock 15.3 Hypertensive Emergency & Urgency Management
16 Chapter 16: Vascular & Thromboembolic Emergencies
16.1 Pulmonary Embolism & Deep Vein Thrombosis 16.2 Acute Aortic Syndromes & Peripheral Vascular Emergencies 16.3 Critical Limb Ischemia & Acute Arterial Occlusion
17 Chapter 17: Neurologic Emergencies: Stroke & Altered Consciousness
17.1 Acute Ischemic Stroke & Intracranial Hemorrhage 17.2 Syncope Evaluation & Status Epilepticus 17.3 Acute Delirium, Encephalopathy & Severe Confusion
18 Chapter 18: Neurologic Trauma & Acute Cranial Emergencies
18.1 Concussion, Moderate-to-Severe TBI & Intracranial Injury 18.2 Thunderclap & Acute Severe Secondary Headaches 18.3 Acute Ophthalmologic Emergencies
19 Chapter 19: Acute Abdominal, Pelvic & Gastrointestinal Emergencies
19.1 Acute Abdominal & Pelvic Pain Triage 19.2 Upper & Lower Gastrointestinal Bleeding 19.3 Acute Hepatic Failure, Cholangitis & Severe Jaundice
20 Chapter 20: Acute Pulmonary & Airway Emergencies
20.1 Acute Hypoxic Respiratory Failure & ARDS 20.2 Severe Community-Acquired Pneumonia & Empyema 20.3 Acute Severe Epistaxis & Airway Obstruction
21 Chapter 21: Acute Traumatic Injuries & Wound Care
21.1 Major Trauma Resuscitation & Initial Assessment 21.2 Burn Assessment, Inhalation Injury & Resuscitation 21.3 Laceration Management, Complex Wounds & Animal Bites
22 Chapter 22: Acute Orthopedic & Musculoskeletal Emergencies
22.1 Acute Ambulatory Fractures & Initial Splinting 22.2 Compartment Syndrome & Major Orthopedic Trauma 22.3 Septic Arthritis & Acute Microcrystalline Crises
23 Chapter 23: Severe Infections, Sepsis & Systemic Emergencies
23.1 Sepsis, Septic Shock & Initial Fluid Resuscitation 23.2 Necrotizing Soft Tissue Infections & Severe CNS Infections 23.3 Anaphylaxis Diagnosis, Epinephrine Dosing & Airway Protection
24 Chapter 24: Metabolic, Endocrine & Electrolyte Emergencies
24.1 Diabetic Ketoacidosis & Hyperosmolar Hyperglycemic State 24.2 Critical Electrolyte Emergencies: Dyskalemias & Dysnatremias 24.3 Severe Calcium Abnormalities & Acute Adrenal Crisis
25 Chapter 25: Hematologic, Urologic & Dental Emergencies
25.1 Severe Symptomatic Anemias & Coagulopathic Emergencies 25.2 Testicular Torsion, Priapism & Acute Urinary Retention 25.3 Urgent Odontogenic Infections & Dental Trauma
26 Chapter 26: Psychiatric, Behavioral & Obstetric/Gynecologic Emergencies
26.1 Suicidal Ideation, Acute Agitation & Behavioral Emergencies 26.2 Acute Physical & Sexual Assault Care 26.3 Life-Threatening Vaginal Bleeding & Ectopic Pregnancy 26.4 Environmental Heat Stroke & Severe Hypothermia
27 Chapter 27: Acute Head, Neck & Neurologic Symptoms
27.1 Primary Acute Headaches: Migraine, Tension & Cluster 27.2 Concussion & Minor Closed Head Injury Evaluation 27.3 Transient Ischemic Attack Evaluation & ABCD2 Risk Scoring
28 Chapter 28: Acute Cranial Nerves, Hearing & Sensory Symptoms
28.1 Peripheral Neuropathies: Bell's Palsy, Carpal Tunnel & Radiculopathy 28.2 Acute Tinnitus, Sudden Sensorineural Hearing Loss & Cerumen Impaction 28.3 Acute Dizziness, Benign Paroxysmal Positional Vertigo & Vestibular Neuritis
29 Chapter 29: Acute Upper Respiratory Tract Infections
29.1 Acute Viral Rhinosinusitis vs. Bacterial Rhinosinusitis 29.2 Acute Pharyngitis: Group A Streptococcus & Centor Criteria 29.3 Acute Otitis Media, Otitis Externa & Serous Effusion
30 Chapter 30: Acute Lower Respiratory Infections & Cough
30.1 Influenza, COVID-19 & Viral Respiratory Syndromes 30.2 Acute Bronchitis & Lower Respiratory Tract Infections 30.3 Ambulatory Community-Acquired Pneumonia
31 Chapter 31: Allergic, Nasal & Non-Infectious Pulmonary Conditions
31.1 Allergic Rhinitis & Acute Non-Anaphylactic Allergic Reactions 31.2 Acute Dyspnea in Ambulatory Care 31.3 Interstitial Lung Diseases & Sarcoidosis Presentation
32 Chapter 32: Acute Chest, Cardiac & Vascular Symptoms
32.1 Palpitations Evaluation & Arrhythmia Triage in Primary Care 32.2 Deep Vein Thrombosis & Superficial Thrombophlebitis 32.3 Ambulatory Hypotension & Orthostasis Evaluation
33 Chapter 33: Acute Upper Gastrointestinal Conditions
33.1 Peptic Ulcer Disease & Gastritis 33.2 Dysphagia, Esophagitis & Acute Esophageal Disorders 33.3 Acute Nausea, Vomiting & Foodborne Illness
34 Chapter 34: Acute Lower Gastrointestinal Conditions
34.1 Acute Infectious Diarrhea & Gastroenteritis 34.2 Acute Constipation & Functional Bowel Changes 34.3 Ano-Rectal Disorders: Hemorrhoids, Fissures, Abscesses & Pruritus Ani
35 Chapter 35: Inflammatory, Functional & Malabsorptive GI Disorders
35.1 Acute Flares of Inflammatory Bowel Disease 35.2 Irritable Bowel Syndrome: Diagnosis, Subtyping & Management 35.3 Celiac Disease & Malabsorption Syndromes
36 Chapter 36: Acute Abdominal, Hepatic & Biliary Disorders
36.1 Ambulatory Abdominal & Pelvic Pain Triage 36.2 Acute Cholecystitis, Biliary Colic & Pancreatitis 36.3 Acute Liver Injury & Viral Hepatitis
37 Chapter 37: Acute Abdominal Wall, Hernias & Dental Conditions
37.1 Abdominal Wall, Inguinal & Ventral Hernias 37.2 Acute Dental Pain, Odontogenic Abscess & Aphthous Ulcers 37.3 Acute Edema: Unilateral vs. Bilateral Diagnostic Evaluation
38 Chapter 38: Acute Infectious Dermatoses
38.1 Bacterial Skin Infections: Impetigo, Cellulitis & Cutaneous Abscesses 38.2 Fungal Skin Infections: Tinea Corporis, Cruris, Pedis & Onychomycosis 38.3 Viral Cutaneous Infections: Herpes Simplex, Zoster & Molluscum Contagiosum
39 Chapter 39: Inflammatory, Allergic & Autoimmune Dermatoses
39.1 Atopic Dermatitis, Contact Dermatitis & Eczematous Flares 39.2 Non-Infectious Rashes: Urticaria, Drug Eruptions & Erythema Multiforme 39.3 Cutaneous Malignancies & Premalignant Lesions: AK, BCC, SCC & Melanoma
40 Chapter 40: Acute Shoulder, Elbow & Upper Extremity Injuries
40.1 Rotator Cuff Pathology, Tendinopathy & Shoulder Impingement 40.2 Lateral & Medial Epicondylitis, Olecranon Bursitis & Elbow Sprains 40.3 Wrist & Hand Soft-Tissue Injuries: De Quervain, TFCC & Finger Sprains
41 Chapter 41: Acute Knee, Ankle & Lower Extremity Injuries
41.1 Meniscal Tears, Ligamentous Knee Injuries & Patellofemoral Pain 41.2 Ankle Sprains, Ottawa Ankle Rules & Achilles Tendinopathy 41.3 Plantar Fasciitis, Shin Splints & Overuse Syndromes
42 Chapter 42: Acute Ambulatory Fractures & Dislocations
42.1 Distal Radius, Scaphoid & Common Upper Extremity Fractures 42.2 Metatarsal, Clavicle & Common Lower Extremity Fractures 42.3 Joint Dislocation Management: Nursemaid's Elbow & Shoulder Subluxation
43 Chapter 43: Acute Axial Musculoskeletal Pain & Falls
43.1 Acute Low Back Pain: Red Flags, Strain & Disc Herniation 43.2 Acute Cervical Strain, Whiplash & Axial Neck Pain 43.3 Evaluation of Falls in Ambulatory & Older Patients
44 Chapter 44: Acute Inflammatory Arthropathies & Generalized Pain
44.1 Acute Inflammatory Arthritis & Spondyloarthropathies 44.2 Myalgias, Rhabdomyolysis & Post-Viral Pain Syndromes 44.3 Acute Non-Headache Pain Management Strategies
45 Chapter 45: Acute Renal, Urinary & Genitourinary Conditions
45.1 Uncomplicated UTI, Pyelonephritis & Acute Urethritis 45.2 Hematuria Workup & Glomerulonephritis 45.3 Nephrolithiasis & Acute Urinary Tract Obstruction
46 Chapter 46: Acute Male Genitourinary & Prostatic Conditions
46.1 Acute Prostatitis, Epididymitis & Orchitis 46.2 Acute Scrotal Pain: Torsion vs Appendage, BPH & Male Genital Emergencies 46.3 Acute Urinary Retention & Incontinence Evaluation
47 Chapter 47: Acute Women's Health & Early Pregnancy Care
47.1 Early Pregnancy Diagnosis, Dating & Initial Complications 47.2 Abnormal Uterine Bleeding & Acute Menstrual Disorders 47.3 Premenstrual Syndrome & Premenstrual Dysphoric Disorder
48 Chapter 48: Breast Disorders, STIs & Pediatric Elimination
48.1 Palpable Breast Mass, Mastitis & Nipple Discharge 48.2 Sexually Transmitted Infections: Diagnosis, Staging & CDC Guidelines 48.3 Pediatric Enuresis & Encopresis
49 Chapter 49: Systemic Signs, Metabolic Dysregulation & Miscellaneous Infections
49.1 Acute Fever, Sepsis Screening & FUO in Primary Care 49.2 Acute Hyperglycemia & Symptomatic Hypoglycemia 49.3 Electrolyte Abnormalities: Mild-to-Moderate Disturbances 49.4 Vector-Borne, Tick-Borne & Rickettsial Illnesses
50 Chapter 50: Chronic Cardiovascular Diseases: Hypertension & Ischemia
50.1 Essential Hypertension Management: 2025 AHA/ACC Guideline & JNC Strategies 50.2 Chronic Coronary Artery Disease & Post-MI Secondary Prevention 50.3 Chronic Heart Failure: HFrEF, HFpEF & Quadruple GDMT
51 Chapter 51: Chronic Vascular, Valvular & Dyslipidemic Diseases
51.1 Peripheral Arterial Disease & Claudication 51.2 Chronic Valvular Heart Disease & Murmur Evaluation 51.3 Lipid Disorders & ASCVD Risk-Based Statin Therapy
52 Chapter 52: Chronic Respiratory Diseases: Asthma & COPD
52.1 Chronic Asthma Management: GINA Stepwise SMART Therapy 52.2 Chronic Obstructive Pulmonary Disease: GOLD Recommendations 52.3 Solitary Pulmonary Nodule Evaluation & Fleischner Society Criteria
53 Chapter 53: Chronic Metabolic Diseases: Diabetes Mellitus
53.1 Type 2 Diabetes Management: ADA Pharmacotherapy Algorithms 53.2 Type 1 Diabetes: Basal-Bolus Insulin, CGMs & Diabetic Complications 53.3 Diabetic Microvascular & Macrovascular Disease Surveillance
54 Chapter 54: Obesity, Nutrition & Metabolic Bone Diseases
54.1 Medical & Behavioral Management of Obesity & Incretin Mimetics 54.2 Osteoporosis & Metabolic Bone Disease: DEXA, FRAX & Antiresorptives 54.3 Nutritional Deficiencies: Vitamin D, B12, Iron & Malnutrition
55 Chapter 55: Chronic Endocrine Disorders
55.1 Primary & Subclinical Hypothyroidism, Hyperthyroidism & Nodules 55.2 Adrenal Disorders: Addison's Disease & Cushing's Syndrome 55.3 Hypercalcemia, Hyperparathyroidism & Pituitary Disorders
56 Chapter 56: Chronic Kidney Disease & Venous Disorders
56.1 Chronic Kidney Disease: KDIGO Staging & Renoprotective Therapy 56.2 Chronic Venous Insufficiency, Stasis Dermatitis & Lymphedema 56.3 Chronic Electrolyte & Acid-Base Management in CKD
57 Chapter 57: Chronic Gastrointestinal & Hepatic Diseases
57.1 Gastroesophageal Reflux Disease, Barrett's Esophagus & Dyspepsia 57.2 Chronic Liver Disease: MASLD/NAFLD, Cirrhosis & Portal Hypertension 57.3 Viral Hepatitis B & C: Long-Term Monitoring & DAA Therapy
58 Chapter 58: Colorectal Surveillance & Chronic Pancreaticobiliary Care
58.1 Post-Polypectomy Colorectal Polyp Surveillance Guidelines 58.2 Chronic Pancreatitis & Exocrine Pancreatic Insufficiency 58.3 Chronic Nausea, Gastroparesis & Functional GI Disorders
59 Chapter 59: Chronic Musculoskeletal & Rheumatologic Disorders
59.1 Osteoarthritis: Hip, Knee & Hand Management 59.2 Spinal Conditions: Spinal Stenosis, Spondylolisthesis & Compression Fractures 59.3 Chronic Myopathies & Fibromyalgia Syndrome
60 Chapter 60: Chronic Neurologic & Neurodegenerative Disorders
60.1 Dementia: Alzheimer's, Vascular & Lewy Body Disease 60.2 Parkinson's Disease & Essential Tremor 60.3 Epilepsy: Chronic Antiseizure Medications & Post-Stroke Care
61 Chapter 61: Chronic Peripheral Nerves, Pain & Sensory Disorders
61.1 Diabetic & Chronic Peripheral Neuropathies 61.2 Chronic Pain Syndromes & Chronic Daily Headaches 61.3 Chronic Tinnitus, Presbycusis & Persistent Dizziness
62 Chapter 62: Chronic Psychiatric Disorders
62.1 Major Depressive Disorder & Generalized Anxiety Disorder 62.2 Bipolar Disorder: Maintenance Pharmacotherapy & Lithium Monitoring 62.3 Adult & Pediatric Attention-Deficit/Hyperactivity Disorder
63 Chapter 63: Chronic Behavioral Health & Neurodevelopmental Conditions
63.1 Chronic Behavioral Conditions: PTSD, OCD & Somatization 63.2 Autism Spectrum Disorder & Intellectual Disabilities 63.3 Eating Disorders: Anorexia Nervosa, Bulimia & Binge Eating
64 Chapter 64: Chronic Substance Use Disorders & Tobacco Cessation
64.1 Alcohol Use Disorder: Pharmacotherapy & Relapse Prevention 64.2 Opioid & Stimulant Use Disorders: MOUD & Harm Reduction 64.3 Longitudinal Tobacco Cessation Pharmacotherapy
65 Chapter 65: Chronic Dermatologic Conditions
65.1 Acne Vulgaris, Rosacea & Seborrheic Dermatitis 65.2 Chronic Plaque Psoriasis & Biologic Therapies 65.3 Chronic Eczema, Hidradenitis Suppurativa & Cutaneous Lupus
66 Chapter 66: Chronic Reproductive, Infectious & Geriatric Special Care
66.1 Chronic Menstrual Disorders, Infertility & Sexual Dysfunction 66.2 Menopause Management & Hormone Replacement Therapy 66.3 Chronic HIV Infection Management & Primary Care Integration 66.4 Gender-Affirming Primary Care & Hormone Therapy 66.5 Advance Care Planning, Palliative Care & End-of-Life Symptom Control
67 Chapter 67: Continuity Care: Sleep, Fatigue, Cancer, Pregnancy & the Adult Preventive Visit
67.1 Chronic Insomnia & Obstructive Sleep Apnea 67.2 Chronic Malaise, Fatigue & ME/CFS 67.3 Primary Care During Cancer Treatment & Survivorship 67.4 Routine Prenatal Care & Longitudinal Pregnancy Management 67.5 The Periodic Adult Health Examination & Medicare Annual Wellness Visit
20.3 Acute Severe Epistaxis & Airway Obstruction
Key Takeaways Explain This Topic AI
Anterior epistaxis accounts for approximately 90% of cases and arises from Kiesselbach's plexus (Little's area) on the anterior nasal septum; first-line management requires firm, uninterrupted digital compression over the soft lower third of the nose for 10 to 15 minutes with the patient leaning forward, followed by topical vasoconstrictor/anesthetic application and unilateral silver nitrate cautery (never cauterize opposing bilateral septal surfaces simultaneously due to risk of ischemic cartilage necrosis and septal perforation).
Posterior epistaxis arises from Woodruff's plexus or the sphenopalatine artery, presenting with profuse arterial hemorrhage flowing down the posterior oropharynx in older, hypertensive, or anticoagulated patients; it requires emergency posterior balloon or Foley catheter tamponade paired with anterior packing, mandatory hospital admission with continuous pulse oximetry and telemetry (due to hypoxia and vagal bradycardia via the nasopulmonary reflex), and urgent otolaryngology intervention.
Acute epiglottitis is a life-threatening supraglottic cellulitis presenting with the classic triad of the '3 D's' (Drooling, Dysphagia, Distress), muffled 'hot potato' voice, and tripod positioning; invasive oral examination with a tongue depressor is strictly contraindicated outside of the operating room because it can precipitate fatal reflex laryngospasm, requiring immediate transfer to the operating room for controlled awake fiberoptic or surgical airway placement.
Ludwig's angina is a rapidly spreading, non-suppurative, bilateral cellulitis of the submandibular, sublingual, and submental spaces typically originating from infected mandibular second or third molars; it produces woody submandibular induration ('bull neck') and tongue elevation/protrusion, mandating emergency awake flexible fiberoptic intubation (direct laryngoscopy is contraindicated due to airway distortion), high-dose broad-spectrum IV antibiotics (e.g., ampicillin-sulbactam), and surgical decompression.
Acute angioedema must be rapidly differentiated: histaminergic angioedema is accompanied by urticaria and pruritus and responds rapidly to intramuscular epinephrine, antihistamines, and corticosteroids; in contrast, bradykinin-mediated angioedema (ACE inhibitor-induced or hereditary C1-esterase inhibitor deficiency) lacks urticaria, is completely refractory to epinephrine and steroids, and mandates immediate airway evaluation alongside targeted therapies including C1-INH concentrate, icatibant, or fresh frozen plasma.
Last updated: September 2026
Acute Epistaxis: Vascular Anatomy, Triage & Emergency Protocols
Epistaxis is one of the most frequent otolaryngologic emergencies encountered in primary care and emergency settings, affecting approximately 60% of individuals during their lifetime, with 6% requiring professional medical intervention. Rapid management requires localizing the bleeding source to either the anterior or posterior nasal cavity.
Vascular Anatomy: Kiesselbach's vs. Woodruff's Plexus NASAL SEPTAL VASCULAR ANATOMY
- Anterior Ethmoidal Artery (Internal Carotid)
- │
- ▼
- Posterior Ethmoidal Artery ──> ┌──────────────┐ <── Sphenopalatine Artery
- (Internal Carotid) │ KIESSELBACH │ (External Carotid: Terminal IMAX)
- │ PLEXUS │
- Superior Labial Artery ──────> │(Little's Area│ <── Greater Palatine Artery
- (External Carotid: Facial) └──────────────┘ (External Carotid: IMAX)
- │
- ▼
- ANTERIOR SEPTAL HEMORRHAGE (~90%)
- (Digital Compression / Silver Nitrate / Tampon)
─────────────────────────────────────────────────────────────────────────────
POSTERIOR VASCULAR SUPPLY
- Sphenopalatine Artery (IMAX) + Ascending Pharyngeal Artery
- │
- ▼
- ┌────────────────┐
- │ WOODRUFF'S │
- │ PLEXUS │
- └────────────────┘
- │
- ▼
- POSTERIOR ARTERIAL HEMORRHAGE (~10%)
- (Profuse / Bilateral / Down Posterior Oropharynx)
- (Mandatory Posterior Balloon Pack + Hospital Telemetry)
Anterior Epistaxis (~90% of cases) :
Anatomical Site : Kiesselbach's plexus (also designated Little's area ), located on the anterior inferior third of the cartilaginous nasal septum.
Arterial Anastomosis : Formed by the confluence of five arteries derived from both the internal and external carotid systems:
- Anterior ethmoidal artery (from ophthalmic artery / internal carotid);
- Posterior ethmoidal artery (from ophthalmic artery / internal carotid);
- Sphenopalatine artery (terminal branch of internal maxillary artery / external carotid);
- Greater palatine artery (from internal maxillary artery / external carotid);
Superior labial artery (septal branch of facial artery / external carotid).
Clinical Features : Typically unilateral, low-pressure capillary or small arteriolar bleeding. Readily visualized via anterior rhinoscopy. Commonly triggered by digital trauma (nose picking), mucosal dryness from low ambient humidity, upper respiratory infections, allergic rhinitis, or chronic misuse of topical nasal corticosteroids directed toward the septum rather than the lateral nasal wall.
Posterior Epistaxis (~10% of cases) :
Anatomical Site : Woodruff's plexus , located on the lateral nasal wall inferior to the posterior aspect of the inferior turbinate, or directly from the trunk and posterior branches of the sphenopalatine artery as it emerges from the sphenopalatine foramen.
Clinical Features : High-pressure arterial bleeding that flows profusely down the posterior oropharynx regardless of patient position. Difficult or impossible to visualize on anterior rhinoscopy. Typically occurs in older adults with longstanding essential hypertension, severe systemic atherosclerosis, coagulopathy, liver disease, or those receiving therapeutic anticoagulation (warfarin, direct oral anticoagulants) or antiplatelet agents.
- Stepwise Emergency Management of Anterior Epistaxis
- Step 1: Patient Positioning and Airway Protection
Seat the patient completely upright, leaning slightly forward at the waist , with the mouth open, allowing blood to drain into an emesis basin.
Strict Warning : The historical maneuver of tilting the head backward is dangerous and strictly obsolete . Tilting the head back diverts blood into the hypopharynx, causing blood ingestion (which produces severe gastric irritation, nausea, and hematemesis) and significantly increases the risk of tracheobronchial aspiration and airway compromise.
Instruct the patient to gently blow the nose once to evacuate non-hemostatic, jelly-like clots that prevent direct vessel tamponade.
Step 2: Direct Continuous Digital Compression
Apply firm, uninterrupted manual compression directly over the soft, cartilaginous lower third of the nose , pinching both alae nasi tightly against the nasal septum.
Compression must be held continuously for 10 to 15 full minutes by the clock without releasing pressure to check for cessation of bleeding.
Common Error : Pinching the bridge of the nose (the rigid nasal bones of the upper third) applies zero compressive force to Kiesselbach's plexus and is completely ineffective.
Step 3: Topical Vasoconstrictors and Local Anesthesia
If bleeding persists despite 15 minutes of firm compression: insert cotton pledgets soaked in a topical vasoconstrictor ( 0.05% oxymetazoline [Afrin] or 1% phenylephrine ) combined with a rapid-acting topical anesthetic ( 4% lidocaine or cocaine solution).
Reapply continuous digital compression over the soft lower third for an additional 10 minutes. This induces mucosal vasoconstriction and achieves anesthesia for subsequent examination and cauterization.
Step 4: Chemical Cautery with Silver Nitrate
Remove the cotton pledgets and perform anterior rhinoscopy utilizing a nasal speculum, suction catheter, and focused headlamp.
If an active focal bleeding point or a prominent, non-bleeding prominent vessel with surrounding clot is clearly identified:
Apply a silver nitrate ( A g N O 3 AgNO_3 A g N O 3 ) applicator tip directly to the mucosa.
Technique : Roll the applicator tip circumferentially around the peripheral margin of the bleeding vessel first to seal the feeding vessels, and then apply it gently onto the center of the bleeding site for no more than 3 to 5 seconds until a grey-white eschar forms.
Caution
THE ABSOLUTE CONTRAINDICATION TO BILATERAL CHEMICAL CAUTERY: NEVER apply silver nitrate cautery to bilateral opposing surfaces of the nasal septum simultaneously (or during the same procedural visit). The cartilaginous nasal septum is an avascular structure that relies entirely on nutrient diffusion from the overlying mucoperichondrium on either side. Applying caustic silver nitrate to both sides of the septum simultaneously destroys the perichondrial microvasculature bilaterally, causing full-thickness ischemic chondronecrosis of the septal cartilage . This results in a permanent, irreversible septal perforation , leading to chronic whistling, crusting, turbulent airflow, and intractable recurrent epistaxis.
Step 5: Anterior Nasal Packing
Indicated when direct compression and chemical cautery fail to achieve hemostasis, or when no discrete bleeding site can be visualized:
Polyvinyl Alcohol Sponge Nasal Tampon (Merocel) : Coated with water-soluble antibiotic ointment, inserted gently along the floor of the nasal cavity parallel to the hard palate, and rehydrated with 5 to 10 mL of normal saline or topical tranexamic acid (TXA, 500 mg) , causing the sponge to expand and exert uniform mechanical pressure.
Pneumatic Nasal Catheter (Rapid Rhino) : Hydrocolloid-coated carboxymethylcellulose pack soaked in sterile water for 30 seconds, inserted along the nasal floor, and gently inflated with air via a 20-mL syringe until bleeding halts.
Antibiotic Prophylaxis Debate : In situ nasal packing creates a stagnant, blood-filled aerobic-anaerobic medium that promotes colonization by Staphylococcus aureus capable of secreting Toxic Shock Syndrome Toxin-1 (TSST-1). To prevent Toxic Shock Syndrome (TSS) , guidelines recommend prescribing oral amoxicillin-clavulanate (875/125 mg PO BID) or cephalexin (500 mg PO QID) while non-absorbable packing remains in place. Non-absorbable packing must be removed within 48 to 72 hours .
Management of Posterior Epistaxis
Posterior epistaxis is a true medical emergency characterized by refractory hemorrhage that continues to flow vigorously down the posterior pharynx despite correctly positioned anterior packing.
Emergency Posterior Tamponade Techniques
Dual-Balloon Pneumatic Catheter (e.g., Epistat / Rapid Rhino Posterior) :
Lubricated and inserted along the floor of the nasal cavity into the nasopharynx.
The posterior balloon is inflated with 5 to 10 mL of sterile water (never air, which can leak, and never saline, which can crystallize and damage the valve) and gently pulled forward until firmly lodged in the posterior choana.
The anterior balloon is then inflated with 10 to 15 mL of sterile water to achieve anterior tamponade.
Foley Catheter Technique :
In the absence of a dedicated commercial balloon catheter: pass a 12 to 14 French Foley catheter with a 30-mL balloon along the nasal floor until the tip is visible in the posterior oropharynx.
Inflate the balloon with 5 to 10 mL of sterile water , and gently traction the catheter anteriorly until the balloon wedges securely against the posterior choana.
While maintaining continuous forward traction, place formal anterior nasal packing.
Secure the catheter at the external naris using an umbilical clamp or plastic clip , placing generous gauze padding between the clamp and the nasal ala to prevent pressure-induced necrosis of the alar cartilage.
The Nasopulmonary Reflex & Mandatory Inpatient Admission
Important
MANDATORY INPATIENT TELEMETRY ADMISSION FOR ALL POSTERIOR PACKS: Every patient with a posterior nasal pack must be admitted to an inpatient telemetry or step-down unit with continuous pulse oximetry and cardiac monitoring .
Mechanical distension of the posterior nasopharynx stimulates sensory afferents of the trigeminal (V2) and glossopharyngeal (CN IX) nerves, triggering the nasopulmonary reflex . This profound vagal reflex produces severe central respiratory depression, arterial hypoxemia, hypercapnia, severe bradycardia, malignant cardiac dysrhythmias, and sudden cardiac arrest, especially in elderly patients with pre-existing cardiopulmonary disease.
Refractory Posterior Hemorrhage
If posterior bleeding persists despite balloon tamponade, urgent Otolaryngology consultation is mandatory for:
Endoscopic Sphenopalatine Artery Ligation (ESPAL) : Direct transantronasal clip ligation of the sphenopalatine artery branches (success rate >95%); OR
Endovascular Interventional Embolization : Superselective catheter-directed embolization of the internal maxillary artery branches under fluoroscopy.
Acute Upper Airway Obstruction
Acute upper airway obstruction is a catastrophic medical emergency that can progress to complete asphyxiation, anoxic brain injury, and death within 3 to 5 minutes if untreated.
1. Foreign Body Airway Obstruction (FBAO)
Recognition : Sudden onset of respiratory distress while eating or playing, characterized by the universal choking sign (hands clutching the neck), aphonia (inability to speak), ineffective cough, inspiratory stridor, and rapidly developing cyanosis.
Emergency Resuscitation Protocols by Patient Category
Conscious Adult or Child >1 Year :
Perform subdiaphragmatic abdominal thrusts (Heimlich Maneuver) : Stand behind the patient, wrap arms around the waist, make a fist with one hand, place the thumb side of the fist against the patient's abdomen midway between the umbilicus and the xiphoid process, grasp the fist with the other hand, and deliver rapid, inward and upward thrusts until the object is expelled.
Special Populations : In visibly pregnant women or morbidly obese patients where abdominal thrusts cannot be performed, deliver chest thrusts over the lower third of the sternum.
Conscious Infant (<1 Year) :
Place the infant prone along the rescuer's forearm with the head positioned lower than the trunk, supporting the infant's jaw and head with the hand.
Deliver 5 firm back slaps / blows between the infant's scapulae using the heel of the hand.
Turn the infant supine onto the opposite forearm (head still lower than trunk) and deliver 5 rapid chest thrusts over the lower half of the sternum (depressing approximately 1.5 inches / 4 cm).
Repeat alternating cycles of 5 back blows and 5 chest thrusts until the foreign object is dislodged or the infant loses consciousness.
Strict Rule : Abdominal thrusts are STRICTLY CONTRAINDICATED in infants <1 year due to the high risk of catastrophic hepatic laceration and intra-abdominal hemorrhage.
Unconscious Choking Patient (All Ages) :
Lower the patient gently to the ground, activate emergency medical services (call 911), and immediately initiate Cardiopulmonary Resuscitation (CPR) , beginning with 30 chest compressions.
Each time the airway is opened to deliver rescue breaths: visually inspect the posterior oropharynx .
If a foreign object is clearly visualized, remove it with a targeted finger sweep.
NEVER perform a blind finger sweep : Blind sweeps push an unseen foreign body deeper from the hypopharynx into the laryngeal inlet, converting a partial obstruction into an irreversible complete obstruction.
2. Acute Epiglottitis (Supraglottitis)
Acute epiglottitis is a rapidly progressive bacterial cellulitis and edema of the supraglottic structures, including the epiglottis, aryepiglottic folds, and arytenoid soft tissues.
Etiology and Microbiology
Historically driven by Haemophilus influenzae type b (Hib) in young children. Following widespread routine Hib conjugate vaccination, the pediatric incidence declined by >90%.
Current cases occur primarily in unvaccinated children and adults (mean age 45 to 55 years).
Dominant pathogens: Streptococcus pneumoniae , Haemophilus influenzae (non-typeable and Hib), Staphylococcus aureus (including MRSA), and Group A Streptococcus ( Streptococcus pyogenes ).
Clinical Presentation: The Cardinal "3 D's"
Rapid onset of severe sore throat, high fever, toxic appearance, and severe odynophagia that is dramatically out of proportion to mild pharyngeal erythema on superficial inspection.
The Classic Triad of the "3 D's" :
- Drooling : Inability to swallow oral secretions due to excruciating odynophagia;
- Dysphagia ;
Distress : Severe inspiratory stridor, tachypnea, and accessory muscle use.
Voice Changes : Muffled "hot potato" voice (supraglottic fullness dampens vocal resonance; vocal cords are unaffected, so hoarseness is typically absent).
Characteristic Posture : The tripod position (patient sits upright, leaning forward with arms braced on knees, neck hyperextended, and chin thrust forward to maintain maximal supraglottic airway diameter).
Diagnostic Imaging: The "Thumbprint Sign"
In a hemodynamically stable patient with a secure airway, a lateral soft tissue radiograph of the neck demonstrates:
The "Thumbprint Sign" : A rounded, enlarged, edematous epiglottis resembling the silhouette of an adult human thumb projecting into the hypopharynx, with obliteration of the vallecular air space.
Safety Rule : Radiographs should NEVER be performed if the patient is in severe respiratory distress or shows signs of airway compromise; imaging must never delay definitive airway management.
Warning
STRICT PROHIBITION OF ORAL EXAMINATION (THE FATAL LARYNGOSPASM WARNING): DO NOT use a wooden tongue depressor, attempt indirect laryngoscopy, or perform oral swabs in a patient with suspected epiglottitis outside of an operating room. Mechanical irritation of the inflamed, hypersensitive supraglottic tissues or acute patient distress can precipitate sudden, catastrophic reflex laryngospasm , resulting in complete, irreversible airway obstruction and immediate cardiac arrest.
Emergency Airway & Medical Management
Maintain Calm : Keep the patient in their chosen position of comfort (allow children to remain in a parent's lap). Avoid invasive procedures, blood draws, or IV lines until the airway is secure.
Controlled Airway Control in the Operating Room :
Immediate mobilization of a multidisciplinary emergency team: Otolaryngology (ENT) and Anesthesiology.
Transport the patient directly to the operating room; perform inhalational induction (sevoflurane) in the sitting position, followed by gentle endotracheal intubation utilizing a flexible fiberoptic bronchoscope or video laryngoscope with an endotracheal tube sized 0.5 to 1.0 mm smaller than normal.
Equipment for an emergent surgical airway ( cricothyrotomy / tracheostomy ) must be open and immediately available at the bedside prior to induction.
Parenteral Antimicrobial Therapy :
Once the airway is secured, obtain blood cultures and initiate high-dose IV antibiotics: C e f t r i a x o n e 2 g IV daily + V a n c o m y c i n 15 to 20 mg/kg IV q8-12h \mathbf{Ceftriaxone\text{ }2\text{ g IV daily}} \quad + \quad \mathbf{Vancomycin\text{ }15\text{ to }20\text{ mg/kg IV q8-12h}} Ceftriaxone 2 g IV daily + Vancomycin 15 to 20 mg/kg IV q8-12h
Intravenous Dexamethasone ( 0.15 mg/kg 0.15\text{ mg/kg} 0.15 mg/kg ) is frequently administered as an adjunctive anti-inflammatory agent to hasten resolution of supraglottic edema.
3. Ludwig's Angina
Ludwig's angina is a rapidly expanding, potentially gangrenous, non-suppurative cellulitis involving the bilateral submandibular, sublingual, and submental fascial spaces .
Pathogenesis & Odontogenic Origin
Odontogenic Source : Over 70 % to 90 % 70\%\text{ to }90\% 70% to 90% of cases originate from an infected mandibular molar—specifically the second or third mandibular molars .
Anatomical Basis : The roots of the second and third lower molars extend inferiorly below the insertion of the mylohyoid muscle on the lingual aspect of the mandible. Periapical dental abscesses or periodontitis in these teeth directly penetrate the thin lingual cortical plate, gaining unimpeded access to both the sublingual space (above the mylohyoid) and the submandibular space (below the mylohyoid).
Microbiology : Virulent polymicrobial oral flora consisting of oral streptococci ( Streptococcus viridans , Streptococcus anginosus ), Staphylococcus aureus , and oral anaerobes ( Peptostreptococcus , Fusobacterium nucleatum , Bacteroides species, and Prevotella ).
Physical Examination Findings
Massive, symmetric, tense, brawny swelling of the bilateral anterior neck and submandibular regions, displaying a firm, unyielding texture ( "woody induration" or "bull neck" appearance).
Elevation and Posterior Displacement of the Tongue : The tongue is pushed superiorly and posteriorly against the hard palate, resulting in severe airway narrowing, severe drooling, inability to swallow secretions, muffled voice, and trismus (inability to open the jaw).
Important Diagnostic Pearl : Ludwig's angina is primarily a rapidly spreading phlegmonous cellulitis rather than an abscess; palpable fluctuance is characteristically ABSENT in the early stages.
Emergency Airway Management
Leading Cause of Death : Asphyxiation caused by the progressive superior-posterior displacement of the tongue occluding the hypopharynx.
Airway Management Mandate :
Standard direct laryngoscopy and blind oral or nasotracheal intubation are strictly contraindicated due to distorted anatomy, severe trismus, tissue rigidity, and the extreme risk of precipitating total airway collapse or laryngospasm.
Gold Standard : Awake flexible fiberoptic nasotracheal intubation performed by an expert airway specialist in the operating room.
If fiberoptic intubation is unsuccessful or anatomically impossible, emergent awake tracheostomy or cricothyrotomy under local anesthesia must be performed immediately.
Pharmacotherapy & Surgical Decompression :
High-dose broad-spectrum intravenous antibiotics initiated immediately:
- Ampicillin-sulbactam (Unasyn) 3 g 3\text{ g} 3 g IV every 6 hours ; OR
- Ceftriaxone 2 g 2\text{ g} 2 g IV daily PLUS Metronidazole 500 mg 500\text{ mg} 500 mg IV every 8 hours ; OR
In penicillin-allergic or septic patients: Vancomycin 15 to 20 mg/kg 15\text{ to }20\text{ mg/kg} 15 to 20 mg/kg IV q12h PLUS Meropenem 1 g 1\text{ g} 1 g IV q8h .
Urgent surgical consultation for wide surgical incision, drainage, and bilateral fascial decompression if purulent collections or tissue tension fail to resolve rapidly with antibiotics.
4. Acute Angioedema: Histaminergic vs. Bradykinin-Mediated
Angioedema is characterized by sudden, localized, non-pitting, transient swelling of the deep dermis, subcutaneous tissue, or submucosal tissues. Rapidly identifying the underlying biochemical mediator is life-saving, as medical treatments are entirely different. DIAGNOSTIC & THERAPEUTIC DIFFERENTIATION
OF ACUTE ANGIOEDEMA
- ┌─────────────────────────────────────────┐ ┌─────────────────────────────────────────┐
- │ HISTAMINERGIC ANGIOEDEMA │ │ BRADYKININ-MEDIATED ANGIOEDEMA │
- ├─────────────────────────────────────────┤ ├─────────────────────────────────────────┤
- │ • Mast cell degranulation (IgE / Type I)│ │ • Kininase II (ACE) block or C1-INH def │
- │ • Rapid onset (minutes to 1-2 hours) │ │ • Indolent onset (hours, peaks 12-24h) │
- │ • URTICARIA (HIVES) & PRURITUS PRESENT │ │ • NO URTICARIA; NO PRURITUS │
- │ • Often wheezing / bronchospasm / shock │ │ • Bowel edema (severe abdominal colic) │
- │ │ │ │
- │ HIGHLY RESPONSIVE TO: │ │ COMPLETELY REFRACTORY TO: │
- │ 1. IM Epinephrine 0.3 mg (1:1,000) │ │ • Epinephrine │
- │ 2. IV Diphenhydramine 50 mg (H1) │ │ • Antihistamines │
- │ 3. IV Famotidine 20 mg (H2) │ │ • Corticosteroids │
- │ 4. IV Methylprednisolone 125 mg │ │ │
- │ │ │ TARGETED RESCUE THERAPY: │
- │ │ │ 1. C1-INH Concentrate (Berinert 20 U/kg)│
- │ │ │ 2. Icatibant (Firazyr 30 mg SubQ) │
- │ │ │ 3. Ecallantide (Kalbitor 30 mg SubQ) │
- │ │ │ 4. Fresh Frozen Plasma (FFP 2-4 units) │
- └─────────────────────────────────────────┘ └─────────────────────────────────────────┘
- Bradykinin-Mediated Angioedema Mechanisms
ACE Inhibitor-Induced Angioedema :
Angiotensin-converting enzyme (ACE) is identical to kininase II , the primary endogenous metalloproteinase that degrades bradykinin.
Pharmacological ACE inhibition halts bradykinin breakdown. Accumulated bradykinin binds to endothelial bradykinin B 2 B_2 B 2 receptors , triggering massive release of nitric oxide and prostacyclin, producing dramatic post-capillary venular vasodilation and increased microvascular permeability.
Occurs in 0.1 % to 0.7 % 0.1\%\text{ to }0.7\% 0.1% to 0.7% of patients receiving ACE inhibitors (with a 5-fold higher incidence in African Americans due to genetic polymorphisms in alternative kinin breakdown enzymes).
Timing Phenomenon : Can manifest within hours of the initial dose, or after months to years of completely uneventful chronic ACE inhibitor therapy .
Hereditary Angioedema (HAE) :
Autosomal dominant deficiency (Type 1, ~85% of cases; low antigenic C1-INH level) or dysfunction (Type 2, ~15% of cases; normal/elevated antigenic level but low functional activity) of C1-esterase inhibitor (C1-INH) .
C1-INH regulates the contact (kallikrein-kinin) system; its absence allows uncontrolled conversion of prekallikrein to kallikrein, generating massive quantities of bradykinin.
Diagnostic Screening : Serum complement C4 concentration is the best initial screening test, remaining persistently low (<50% of normal) even during asymptomatic remission periods.
Emergency Airway Protection in Angioedema
Immediate bedside flexible fiberoptic nasopharyngoscopy must be performed to inspect the uvula, base of the tongue, epiglottis, and false/true vocal cords.
Indications for Prophylactic Awake Fiberoptic Intubation :
Stridor, hoarseness, dyspnea, progressive posterior tongue enlargement, or supraglottic / epiglottic edema.
Intubation must be executed proactively while the airway remains partially open; waiting until full glottic closure transforms a manageable intubation into an emergency surgical airway.